Medication Adherence describes the extent to which a person's medicine-taking behaviour corresponds with an agreed treatment plan. It is broader and generally more patient-centred than the older concept of compliance, because adherence recognises that treatment decisions are ideally made through communication and agreement rather than simple obedience to instructions. Adherence can concern whether a medicine is started, taken at the prescribed dose and frequency, continued for the intended duration and used according to relevant administration requirements. It can therefore vary over time and across medicines within the same person's treatment regimen. Measuring adherence is important because the effectiveness demonstrated in clinical trials cannot be achieved consistently when medicines are not taken as intended.
Medication Adherence can be influenced by intentional and unintentional factors. Intentional non-adherence occurs when a person decides not to take a medicine or changes its use because of concerns, preferences, perceived lack of benefit, side effects, cost, inconvenience or beliefs about treatment. Unintentional non-adherence can result from forgetting, misunderstanding instructions, cognitive difficulties, complex schedules, difficulty swallowing or problems obtaining medicines. The distinction matters because interventions designed for forgetfulness may not address concerns about necessity or adverse effects. Effective support therefore begins with understanding the person's actual reasons rather than assuming that all missed doses reflect the same problem.
Treatment complexity is an important determinant of Medication Adherence. Multiple medicines with different dosing frequencies, special administration instructions or changing schedules increase the cognitive and practical burden of treatment. Long-term preventive medicines may be particularly difficult to maintain because benefits can be invisible while inconveniences or adverse effects are immediate. Simplifying regimens where clinically appropriate can reduce burden. Clear written and verbal instructions, practical routines, reminder systems and accessible packaging can also help. However, simplification cannot compensate for a medicine that the patient does not understand, cannot tolerate or cannot reliably obtain.
Communication and shared decision-making can influence Medication Adherence by improving understanding and aligning treatment with patient priorities. People are more able to follow treatment plans when they understand the purpose of a medicine, expected benefits, important risks and what to do when a dose is missed. Discussing concerns openly can reveal misconceptions, previous negative experiences or practical barriers. Healthcare professionals should avoid assuming that a person who reports missed doses is careless because judgemental communication can discourage honest disclosure. Accurate knowledge of actual medicine-taking behaviour is essential for interpreting whether a treatment appears ineffective.
Measuring Medication Adherence is challenging because no single method is perfect. Self-report is inexpensive and can reveal reasons for missed doses but may be affected by recall or social-desirability bias. Pharmacy refill records can show whether medicines were obtained but cannot prove that they were taken. Electronic monitoring can provide detailed information about opening containers or other events but may be expensive and still cannot prove ingestion. Blood or urine measurements can sometimes demonstrate recent exposure but may not represent long-term behaviour. Combining methods can provide a more informative picture than relying on one measure alone.
Poor Medication Adherence can lead to inadequate disease control, unnecessary treatment escalation and increased healthcare utilisation. Clinicians may incorrectly conclude that a medicine is ineffective if the person has not been taking it consistently, potentially resulting in additional medicines and greater treatment burden. In some conditions, inconsistent exposure can have particularly serious consequences, including loss of preventive benefit or increased risk of treatment failure. Conversely, taking more medicine than instructed can also be harmful and should not be confused with adherence. Adherence means appropriate use according to the agreed regimen, not simply taking as much medicine as possible.
Practical interventions include simplifying dosing schedules, providing reminders, arranging medicine reviews, improving access, addressing side effects and discussing concerns about treatment. Pharmacy-based support can help with refill coordination and education, while digital reminders can assist some people with routine dosing. Financial barriers may require consideration of available healthcare or reimbursement arrangements. Interventions should be matched to the underlying barrier because a person who cannot afford treatment requires a different solution from someone who experiences severe adverse effects or doubts the necessity of treatment.
A common misconception is that Medication Adherence is solely a matter of patient motivation. In reality, adherence can be affected by treatment design, healthcare communication, affordability, access, cognitive demands, side effects and the person's understanding of illness and treatment. Another misconception is that missing a dose always has the same clinical consequence; the significance depends on the particular medicine and treatment objective. Good adherence support is therefore individualised and non-judgemental, with emphasis on understanding barriers, making treatment practicable and ensuring that the treatment plan itself remains acceptable and clinically appropriate.
